Kurt Schlachter
Overview
Explore the profile of Kurt Schlachter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
250
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vill K, Tacke M, Konig A, Baumann M, Baumgartner M, Steinbach M, et al.
J Neurol
. 2024 Feb;
271(5):2787-2797.
PMID: 38409538
Newborn screening for 5qSMA offers the potential for early, ideally pre-symptomatic, therapeutic intervention. However, limited data exist on the outcomes of individuals with 4 copies of SMN2, and there is...
2.
Pechmann A, Behrens M, Dornbrack K, Tassoni A, Wenzel F, Stein S, et al.
Orphanet J Rare Dis
. 2022 Oct;
17(1):384.
PMID: 36274155
Background: The development and approval of disease modifying treatments have dramatically changed disease progression in patients with spinal muscular atrophy (SMA). Nusinersen was approved in Europe in 2017 for the...
3.
Pechmann A, Behrens M, Dornbrack K, Tassoni A, Stein S, Vogt S, et al.
Brain
. 2022 Jul;
146(2):668-677.
PMID: 35857854
5q-associated spinal muscular atrophy is a rare neuromuscular disorder with the leading symptom of a proximal muscle weakness. Three different drugs have been approved by the European Medicines Agency and...
4.
Bernert G, Hahn A, Kohler C, Meyer S, Schara U, Schlachter K, et al.
Nervenarzt
. 2020 Nov;
92(4):359-366.
PMID: 33215271
Background: Duchenne muscular dystrophy (DMD) is the most frequent genetic neuromuscular disease in childhood with loss of ambulation usually occurring around the age of 9-11 years. Objective, Material And Methods:...
5.
Pechmann A, Baumann M, Bernert G, Flotats-Bastardas M, Gruber-Sedlmayr U, von der Hagen M, et al.
J Neuromuscul Dis
. 2019 Nov;
7(1):41-46.
PMID: 31744015
The natural history of patients with spinal muscular atrophy (SMA) has changed due to advances in standard care and development of targeted treatments. Nusinersen was the first drug approved for...
6.
Flotats-Bastardas M, Ebrahimi-Fakhari D, Bernert G, Ziegler A, Schlachter K, Poryo M, et al.
Nervenarzt
. 2019 Jul;
90(8):817-823.
PMID: 31270551
Background: Duchenne muscular dystrophy (DMD) is a severe X‑linked recessive neuromuscular disorder. In children without corticosteroid therapy, progressive muscular weakness is associated with loss of ambulation on average by the...
7.
Lotte J, Bast T, Borusiak P, Coppola A, Cross J, Dimova P, et al.
Seizure
. 2016 Jan;
35:106-10.
PMID: 26820223
Purpose: PCDH19 mutations cause epilepsy and mental retardation limited to females (EFMR) or Dravet-like syndromes. Especially in the first years of life, epilepsy is known to be highly pharmacoresistant. The...
8.
Biro A, Stephani U, Tarallo T, Bast T, Schlachter K, Fleger M, et al.
Neuropediatrics
. 2015 Mar;
46(2):110-6.
PMID: 25730374
Objective: This article aims to report the first clinical experiences concerning effectiveness and tolerability of perampanel (PER) in a pediatric population with refractory epilepsies. Patients And Methods: This nonsponsored, observational,...
9.
Epilepsy, hippocampal sclerosis and febrile seizures linked by common genetic variation around SCN1A
Kasperaviciute D, Catarino C, Matarin M, Leu C, Novy J, Tostevin A, et al.
Brain
. 2013 Sep;
136(Pt 10):3140-50.
PMID: 24014518
Epilepsy comprises several syndromes, amongst the most common being mesial temporal lobe epilepsy with hippocampal sclerosis. Seizures in mesial temporal lobe epilepsy with hippocampal sclerosis are typically drug-resistant, and mesial...
10.
Zotter S, Koch J, Schlachter K, Katzensteiner S, Dorninger L, Brunner J, et al.
Neuropediatrics
. 2013 Aug;
44(6):346-53.
PMID: 23921969
Background: In the majority of patients with Lyme neuroborreliosis (LNB), neurological symptoms are transient. The extent of neuropsychological and neuropsychiatric problems in children is not well researched. Objectives: The study...